AOD-9604 Dosage Guide

What Is the Standard AOD-9604 Dosage?

The most commonly used dosage in research and community settings is 250-300mcg daily administered as a single injection. This range represents the empirically-determined "sweet spot" for fat loss efficacy with minimal side effects. The dosage is typically administered via subcutaneous injection (similar to insulin injections) once daily, preferably morning on an empty stomach.

This dosage range was derived from clinical Phase 2 trials showing efficacy and safety, and has been consistently replicated in community use over years. It provides reliable fat loss benefits for most users without excessive side effects or tolerance development. Doses significantly lower than 250mcg appear less effective, while doses significantly higher than 500mcg provide minimal additional benefit with potentially greater side effect risk.

Should Dosage Be Weight-Based?

AOD-9604 dosing is not universally weight-based the way some medications are. The standard 250-300mcg daily dose works reasonably well across a wide range of body weights (150 lbs to 300+ lbs). Some evidence suggests slightly higher doses may benefit very heavy individuals (250+ lbs), while lighter individuals (under 150 lbs) sometimes report excellent results at 200mcg daily.

A more nuanced approach: start at 250mcg and assess results after 4 weeks. If fat loss is minimal despite strict diet/training adherence, increase to 300mcg. If sides effects emerge, decrease to 200mcg. Individual tolerance and responsiveness vary; weight provides only rough guidance. Most users find 250-300mcg optimal regardless of bodyweight, suggesting a threshold effect rather than linear dose-response.

What Is the Optimal Injection Timing?

Morning injection on an empty stomach (fasted) is strongly preferred by most users and theoretically optimal. Fasted state means lower circulating glucose and insulin, allowing the body to preferentially mobilize fat for energy rather than using recently-consumed glucose. Injecting 30-60 minutes before breakfast or consuming only coffee/water until 1-2 hours post-injection optimizes this fasted window.

The rationale: AOD-9604 enhances fat breakdown and oxidation; doing this in fasted state amplifies relative fat utilization. While the peptide likely works independent of fasting, the combination appears synergistic. Some users inject pre-workout for additional potential synergy with exercise-induced fat mobilization, though evidence for this is anecdotal.

Should I Dose Once or Twice Daily?

Once-daily dosing is standard and sufficient. Clinical trials used once-daily dosing, and community experience confirms that single daily injections produce excellent results. While the peptide's half-life isn't precisely established, evidence suggests that once-daily dosing maintains effective levels for 24 hours, making split dosing unnecessary.

Some users experimentally try twice-daily dosing (125-150mcg twice) but report no superior results compared to single daily dosing, and the added inconvenience usually isn't justified. The standard once-daily protocol is efficient and effective. Only if an individual is insensitive to standard once-daily dosing might split-dosing experimentation be justified, but this is rare.

What Dosages Were Used in Clinical Trials?

The most referenced Phase 2 clinical trial investigated AOD-9604 at doses up to 1mg (1000mcg) daily and showed safety and efficacy across this range in overweight individuals. The trial demonstrated dose-dependent fat loss up to approximately 500mcg daily, with diminishing returns above this threshold. Tolerability was excellent across the study, with minimal adverse events even at the highest tested dose.

These clinical findings support the standard community dosing of 250-300mcg as a safe, effective dose well below the highest tested thresholds. The clinical data provides reassurance that even doubling standard community doses (to 500mcg) remains within tested and tolerated ranges, though unnecessary in most cases for optimal results.

How Is Powdered AOD-9604 Reconstituted?

AOD-9604 is typically purchased as lyophilized (freeze-dried) powder in 2mg or 5mg vials requiring reconstitution before injection. Reconstitute using bacteriostatic water (preservative-containing sterile water), saline, or other sterile diluent according to supplier instructions. For example, 2mg powder reconstituted with 20mL bacteriostatic water creates a concentration of 100mcg per mL—so each 3mL syringe draw would provide 300mcg.

Calculation example: if you want 300mcg daily and have 100mcg/mL, draw 3mL daily. Storage after reconstitution: refrigerate at 2-8°C for extended life (weeks to months depending on diluent purity). Always use sterile techniques and new needles for each draw to prevent contamination and infection risk. Accurate volume measurement is critical—using incorrect dilution creates dosing inaccuracy.

Do I Need to Escalate Dosage Over Time?

Some tolerance development occurs over 8-12 week cycles, but this is better managed through cycling protocol than dose escalation. Rather than increasing to 400-500mcg to overcome tolerance, taking an off-cycle break (4-8 weeks) restores responsiveness to the original 250-300mcg dose. This approach is safer and more cost-effective than chronic dose escalation.

Escalating doses within a single cycle is not recommended; the better strategy is to maintain consistent 250-300mcg dosing throughout the 8-12 week cycle, then take a break. If you find yourself needing 500+ mcg to achieve results, tolerance has developed and an off-cycle is overdue rather than dose escalation being the solution.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions